Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

codexis inc - CDXS

CDXS

Close Chg Chg %
1.74 0.08 4.60%

Closed Market

1.82

+0.08 (4.60%)

Volume: 786.38K

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Trade Now

Company Overview: codexis inc - CDXS

CDXS Key Data

Open

$1.67

 Day Range

1.67 - 1.82

52 Week Range

0.96 - 3.87

 Market Cap

$165.38M

Shares Outstanding

90.87M

 Public Float

88.10M

Beta

2.08

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.52

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

3.99M

  

CDXS Performance

1 Week
 
 15.19%
 
1 Month
 
 47.97%
 
3 Months
 
 13.04%
 
1 Year
 
 -14.35%
 
5 Years
 
 -92.51%
 

CDXS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

About codexis inc - CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

CDXS At a Glance

Codexis, Inc.
200 Penobscot Drive
Redwood City, California 94063-4718
Phone 1-650-421-8100 Revenue 70.39M
Industry Chemicals: Specialty Net Income -43,974,000.00
Sector Process Industries 2025 Sales Growth 18.606%
Fiscal Year-end 12 / 2026 Employees 146
View SEC Filings

CDXS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 2.018
Price to Book Ratio 2.919
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -4.546
Enterprise Value to Sales 1.94
Total Debt to Enterprise Value 0.536

CDXS Efficiency

Revenue/Employee 482,102.74
Income Per Employee -301,191.781
Receivables Turnover 6.587
Total Asset Turnover 0.474

CDXS Liquidity

Current Ratio 3.824
Quick Ratio 3.752
Cash Ratio 3.108

CDXS Profitability

Gross Margin 79.492
Operating Margin -54.459
Pretax Margin -62.408
Net Margin -62.475
Return on Assets -29.631
Return on Equity -74.877
Return on Total Capital -35.538
Return on Invested Capital -35.928

CDXS Capital Structure

Total Debt to Total Equity 144.883
Total Debt to Total Capital 59.164
Total Debt to Total Assets 49.533
Long-Term Debt to Equity 139.057
Long-Term Debt to Total Capital 56.785
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Codexis Inc - CDXS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
138.59M 70.14M 59.34M 70.39M
Sales Growth
+32.30% -49.39% -15.39% +18.61%
Cost of Goods Sold (COGS) incl D&A
43.44M 18.33M 21.13M 14.44M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
10.25M 9.92M 8.13M 8.29M
Depreciation
10.25M 9.92M 8.13M 8.29M
Amortization of Intangibles
- - - -
-
COGS Growth
+71.53% -57.81% +15.31% -31.69%
Gross Income
95.16M 51.82M 38.21M 55.95M
Gross Income Growth
+19.79% -45.55% -26.25% +46.43%
Gross Profit Margin
+68.66% +73.87% +64.39% +79.49%
2022 2023 2024 2025 5-year trend
SG&A Expense
126.87M 106.62M 96.57M 94.28M
Research & Development
80.10M 58.88M 42.30M 48.18M
Other SG&A
46.77M 47.73M 54.27M 46.10M
SGA Growth
+24.22% -15.96% -9.43% -2.36%
Other Operating Expense
- - - -
-
Unusual Expense
2.97M 25.47M 7.07M 3.71M
EBIT after Unusual Expense
(34.68M) (80.27M) (65.42M) (42.04M)
Non Operating Income/Expense
1.36M 4.10M 177.00K (1.89M)
Non-Operating Interest Income
1.44M 4.17M 3.67M 2.63M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(33.32M) (76.17M) (65.24M) (43.93M)
Pretax Income Growth
-57.97% -128.63% +14.35% +32.67%
Pretax Margin
-24.04% -108.59% -109.94% -62.41%
Income Tax
276.00K 69.00K 34.00K 47.00K
Income Tax - Current - Domestic
141.00K 27.00K (6.00K) 7.00K
Income Tax - Current - Foreign
142.00K 42.00K 42.00K 43.00K
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- (7.00K) (2.00K) (3.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(33.59M) (76.24M) (65.28M) (43.97M)
Minority Interest Expense
- - - -
-
Net Income
(33.59M) (76.24M) (65.28M) (43.97M)
Net Income Growth
-57.86% -126.96% +14.38% +32.63%
Net Margin Growth
-24.24% -108.69% -109.99% -62.47%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(33.59M) (76.24M) (65.28M) (43.97M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(33.59M) (76.24M) (65.28M) (43.97M)
EPS (Basic)
-0.5141 -1.119 -0.8892 -0.5046
EPS (Basic) Growth
-55.98% -117.66% +20.54% +43.25%
Basic Shares Outstanding
65.34M 68.13M 73.41M 87.14M
EPS (Diluted)
-0.5141 -1.119 -0.8892 -0.5046
EPS (Diluted) Growth
-55.98% -117.66% +20.54% +43.25%
Diluted Shares Outstanding
65.34M 68.13M 73.41M 87.14M
EBITDA
(21.46M) (44.88M) (50.22M) (30.04M)
EBITDA Growth
-28.14% -109.09% -11.91% +40.19%
EBITDA Margin
-15.49% -63.98% -84.63% -42.68%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 6.75
Number of Ratings 6 Current Quarters Estimate -0.118
FY Report Date 06 / 2026 Current Year's Estimate -0.432
Last Quarter’s Earnings -0.13 Median PE on CY Estimate N/A
Year Ago Earnings -0.50 Next Fiscal Year Estimate -0.36
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 5 4
Mean Estimate -0.12 -0.10 -0.43 -0.36
High Estimates -0.10 -0.08 -0.37 -0.24
Low Estimate -0.14 -0.13 -0.47 -0.42
Coefficient of Variance -13.93 -17.47 -9.60 -22.68

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 5
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Codexis Inc - CDXS

Date Name Shares Transaction Value
Aug 1, 2025 Opaleye Management, Inc. 12,458,422 Open market or private purchase of non-derivative security Non-derivative transaction at $2.82 per share 35,132,750.04
Aug 1, 2025 Opaleye Management, Inc. 12,460,000 Open market or private purchase of non-derivative security Non-derivative transaction at $2.8 per share 34,888,000.00
Apr 18, 2025 Opaleye Management, Inc. 9,605,000 Open market or private purchase of non-derivative security Non-derivative transaction at $2.09 per share 20,074,450.00

Codexis Inc in the News